Categories: NewsTechnology

Tmall Forced To Immediately Halt Over-the-counter Drugs Sales

The Alibaba company runs various online commerce platforms, including Tmall. However, the group has demanded vendors stop offering medicine on the platform, as part of a new directive. Albeit these products seem to be genuine, online platforms have to help their drug sales immediately.

OTC Medicine Sales On Tmall

When consumers think of online commerce platforms such as the ones operated by Alibaba, the last thing most people would purchase is drugs. Healthcare is a serious business, and consumers should never medicine online, regardless of how legitimate the seller may appear to be.

The China Food and Drug Administration has issued a new directive prohibiting drug sales on third-party platforms effectively immediately. No particular reason was given for this instruction, unfortunately. However, the Chinese government wanted to promote online sales of over-the-counter medicine.

By the look of things, the usage of technology to prevent and address issues related to high drug pricing and growing hospital queues did not go as planned. Public hospitals are the dominant market leader when it comes to over-the-counter medicine sales, and online marketplaces were starting to take their claim over the past few months.

An Alibaba spokeswoman told the media that:

“Tmall cooperating and complying with the government’s new policy to stop online drug sales on third-party platforms. While the policy change might impact the whole medicine e-commerce business including Yao.Tmall.com, industry players are exploring new ways to use internet technology to help improve the traditional drug retail system.”

Related Post

Reforming China’s healthcare market will not be as easy as originally assumed. Authorities have expressed their concern regarding the challenges of regulation online drug sales.  With the over-the-counter market set to double in revenue by 2025, regulatory concerns will need to be addressed sooner rather than later.

Unfortunately, this directive will have a big impact on pharmacy chains active on the Tmall platform. The platform had brought in an additional revenue stream for these businesses, all of whom will now have to look for other ways to offer their drugs in an online fashion. This new directive will send shockwaves through the entire pharmacy industry in China, that much is certain.

Source; Reuters

Images credit 1,2

If you liked this article follow us on Twitter @themerklenews and make sure to subscribe to our newsletter to receive the latest bitcoin and altcoin price analysis and the latest cryptocurrency news.

JP Buntinx

JP Buntinx is a FinTech and Bitcoin enthusiast living in Belgium. His passion for finance and technology made him one of the world's leading freelance Bitcoin writers, and he aims to achieve the same level of respect in the FinTech sector.

Share
Published by
JP Buntinx

Recent Posts

ShibaDino is Raising the Bar for Memecoins

With $2,222,222 in liquidity fueling its presale, ShibaDino is proving that memecoins can offer more…

2 hours ago

FTX/Alameda Continues Monthly $SOL Redemption and Distribution, Moving Millions to Major Exchanges

FTX and Alameda Research, two of the most significant players in the cryptocurrency ecosystem, have…

2 days ago

Giant Whale Accumulates $WIF Tokens, Racking Up Profits as Market Moves Favorably

A significant player in the cryptocurrency market has stirred things up by gathering a large…

2 days ago

$LAYER Continues to Thrive Despite Market Volatility, Team’s Innovation Drives Growth

In a cryptocurrency market often marked by wild swings and uncertainty, $LAYER stands as a…

2 days ago

Ethereum Sees Surge in Activity Amidst Growing Resistance and ETF Outflows

One of the top cryptocurrencies in the market, Ethereum ($ETH), has seen a huge rise…

2 days ago

Bitcoin’s Market Dominance Faces Challenges as On-Chain Activity Shifts Towards Ethereum

Bitcoin (BTC) has long held a dominant position in the cryptocurrency market for years. However,…

2 days ago